128 related articles for article (PubMed ID: 30515557)
1. Prognostic subdivision of pT2 rectal carcinomas.
Merkel S; Weber K; Brunner M; Baecker J; Agaimy A; Göhl J; Hohenberger W; Schellerer V; Grützmann R
Int J Colorectal Dis; 2019 Mar; 34(3):409-415. PubMed ID: 30515557
[TBL] [Abstract][Full Text] [Related]
2. Superficial (pT2a) and deep (pT2b) muscle invasion in pathological staging of bladder cancer following radical cystectomy.
Yu RJ; Stein JP; Cai J; Miranda G; Groshen S; Skinner DG
J Urol; 2006 Aug; 176(2):493-8; discussion 498-9. PubMed ID: 16813876
[TBL] [Abstract][Full Text] [Related]
3. Prognostic subdivision of ypT3 rectal tumours according to extension beyond the muscularis propria.
Merkel S; Weber K; Schellerer V; Göhl J; Fietkau R; Agaimy A; Hohenberger W; Hermanek P
Br J Surg; 2014 Apr; 101(5):566-72. PubMed ID: 24477831
[TBL] [Abstract][Full Text] [Related]
4. A novel subclassification of pT2 gastric cancers according to the depth of muscularis propria invasion: superficial muscularis propria versus deep muscularis propria/subserosa.
Sun Z; Zhu GL; Lu C; Guo PT; Huang BJ; Li K; Xu Y; Wang ZN; Xu HM
Ann Surg; 2009 May; 249(5):768-75. PubMed ID: 19387327
[TBL] [Abstract][Full Text] [Related]
5. [The clinical value of further accurate staging of pT2 gastric cancer based on the depth of invasion].
Ding PA; Yang PG; Tian Y; Li F; Guo HH; Liu Y; Zhang ZD; Wang D; Li Y; Zhao Q
Zhonghua Zhong Liu Za Zhi; 2021 Nov; 43(11):1197-1202. PubMed ID: 34794224
[No Abstract] [Full Text] [Related]
6. Analysis of lymph node metastatic pattern according to the depth of in-growth in the muscularis propria in T2 rectal cancer for lateral lymph node dissection.
Komori K; Kanemitsu Y; Ishiguro S; Shimizu Y; Sano T; Kato T
Dig Surg; 2011; 28(5-6):352-9. PubMed ID: 22042151
[TBL] [Abstract][Full Text] [Related]
7. Is subdivision of pT2 tumors superior to lymph node metastasis for predicting survival of patients with gastric cancer? Review of 224 patients from four centers.
Bilici A; Dane F; Seker M; Ustaalioglu BB; Aliustaoglu M; Temiz S; Gezen C; Yavuzer D; Aksu G; Mayadagli A; Gumus M; Uygun K; Turhal NS
Dig Dis Sci; 2011 Nov; 56(11):3226-34. PubMed ID: 21660487
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Factors Among Colonic Adenocarcinomas Invading Into the Muscularis Propria.
Paulsen JD; Polydorides AD
Am J Surg Pathol; 2023 Aug; 47(8):859-868. PubMed ID: 37318139
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of pT sub-classification in surgical pathology of colorectal cancer.
Pollheimer MJ; Kornprat P; Pollheimer VS; Lindtner RA; Schlemmer A; Rehak P; Langner C
Int J Colorectal Dis; 2010 Feb; 25(2):187-96. PubMed ID: 19816699
[TBL] [Abstract][Full Text] [Related]
10. The prognostic inhomogeneity in pT3 rectal carcinomas.
Merkel S; Mansmann U; Siassi M; Papadopoulos T; Hohenberger W; Hermanek P
Int J Colorectal Dis; 2001 Sep; 16(5):298-304. PubMed ID: 11686527
[TBL] [Abstract][Full Text] [Related]
11. Subclassification of pT2 gastric adenocarcinoma according to depth of invasion (pT2a vs pT2b) and lymph node status (pN).
Park DJ; Kong SH; Lee HJ; Kim WH; Yang HK; Lee KU; Choe KJ
Surgery; 2007 Jun; 141(6):757-63. PubMed ID: 17560252
[TBL] [Abstract][Full Text] [Related]
12. The depth of tumor invasion beyond the outer border of the muscularis propria as a prognostic factor for T3 rectal/rectosigmoid cancer.
Yoshida K; Yoshimatsu K; Otani T; Yokomizo H; Ogawa K
Anticancer Res; 2008; 28(3B):1773-8. PubMed ID: 18630458
[TBL] [Abstract][Full Text] [Related]
13. Mesorectal Invasion Depth in Rectal Carcinoma Is Associated With Low Survival.
Lino-Silva LS; Loaeza-Belmont R; Gómez Álvarez MA; Vela-Sarmiento I; Aguilar-Romero JM; Domínguez-Rodríguez JA; Salcedo-Hernández RA; Ruiz-García EB; Maldonado-Martínez HA; Herrera-Gómez Á
Clin Colorectal Cancer; 2017 Mar; 16(1):73-77. PubMed ID: 27364575
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of measured depth of invasion of urothelial carcinoma of the bladder compared to the 2010 American Joint Committee on Cancer pT2 and pT3 classifications.
Zarei S; Frank I; Boorjian SA; Thompson RH; Kim S; Weight C; Tarrell R; Thapa P; Cheville JC
J Urol; 2012 Nov; 188(5):1706-11. PubMed ID: 22998911
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for lymph node metastasis in pT1 and pT2 rectal cancer: a single-institute experience in 943 patients and literature review.
Chang HC; Huang SC; Chen JS; Tang R; Changchien CR; Chiang JM; Yeh CY; Hsieh PS; Tsai WS; Hung HY; You JF
Ann Surg Oncol; 2012 Aug; 19(8):2477-84. PubMed ID: 22396007
[TBL] [Abstract][Full Text] [Related]
16. Collecting system invasion and Fuhrman grade but not tumor size facilitate prognostic stratification of patients with pT2 renal cell carcinoma.
Brookman-May S; May M; Zigeuner R; Shariat SF; Scherr DS; Chromecki T; Moch H; Wild PJ; Mohamad-Al-Ali B; Cindolo L; Wieland WF; Schips L; De Cobelli O; Rocco B; Santoro L; De Nunzio C; Tubaro A; Coman I; Feciche B; Truss M; Dalpiaz O; Hohenfellner M; Gilfrich C; Wirth MP; Burger M; Pahernik S;
J Urol; 2011 Dec; 186(6):2175-81. PubMed ID: 22014800
[TBL] [Abstract][Full Text] [Related]
17. [Multivariate analysis of prognostic factors in endometrial carcinoma].
Li B; Wu LY; Li SM; Zhang WH; Zhang R; Ma SK
Ai Zheng; 2004 Sep; 23(9):1085-8. PubMed ID: 15363208
[TBL] [Abstract][Full Text] [Related]
18. [A single center retrospective study on surgical efficacy of T3NxM0 middle-low rectal cancer without neoadjuvant therapy].
Liu P; Lou Z; Mei Z; Gao X; Hao L; Liu L; Gong H; Meng R; Yu E; Wang H; Wang H; Zhang W
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):66-72. PubMed ID: 30703796
[TBL] [Abstract][Full Text] [Related]
19. The prognostic role of the pathological T2 subclassification for prostate cancer in the 2002 Tumour-Nodes-Metastasis staging system.
van Oort IM; Witjes JA; Kok DE; Kiemeney LA; Hulsbergen-Van De Kaa CA
BJU Int; 2008 Aug; 102(4):438-41. PubMed ID: 18336608
[TBL] [Abstract][Full Text] [Related]
20. Biochemical failure after radical prostatectomy in men with pathologic organ-confined disease: pT2a versus pT2b.
Freedland SJ; Partin AW; Epstein JI; Walsh PC
Cancer; 2004 Apr; 100(8):1646-9. PubMed ID: 15073852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
